Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4268574 | British Journal of Medical and Surgical Urology | 2009 | 6 Pages |
Abstract
Many patients with PCa initiating ADT continue to die from non-cancer causes in an era of widespread PSA testing, the proportion increasing with older age at presentation. This may justify deferring hormonal treatment in suitable older asymptomatic men, sparing the burden of long-term ADT. Patients with PCa who require hormonal therapy should be assessed for cardiovascular and respiratory risk factors at the time of presentation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Vivek K. Wadhwa, Robin Weston, Nigel J. Parr,